Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before starting treatment ...
Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis Overall, 240 patients were randomly ...
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates This study provides continued support for doublet regimens (gemcitabine/nab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results